The National Institute of Allergy and Infectious Diseases said Tuesday that drugmaker AstraZeneca may have submitted “outdated information” about its COVID-19 vaccine that provided an incomplete view of efficacy data from a late-stage clinical trial in the U.S. The development could complicate AstraZeneca’s application to the Food and Drug Administration for emergency use authorization.

Here in New York, Governor Andrew Cuomo says all state residents aged 50 and older are now eligible for a COVID-19 vaccine. Meanwhile, West Virginia has become the third U.S. state to offer vaccines to all adults, joining Alaska and Mississippi. More than 82 million U.S. residents have received at least one dose of vaccine — about one in four people nationwide.